ClinicalTrials.govpublic full text
Prostate Androgen Response Investigation Using a Stratification BIOmarker; Predicting Prostate Cancer Downstaging by Neoadjuvant Darolutamide With PCAI ImmunoScore
prostate cancer (adenocarcinoma), prostate cancer, neoadjuvant, darolutamide, arpi, prediction of treatment response, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 896042
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.